首页> 美国卫生研究院文献>Schizophrenia Bulletin >SA118. Intranasal Oxytocin Does Not Modulate Jumping to Conclusion: S in Schizophrenia: Potential Interaction With Baseline Social Functioning
【2h】

SA118. Intranasal Oxytocin Does Not Modulate Jumping to Conclusion: S in Schizophrenia: Potential Interaction With Baseline Social Functioning

机译:SA118。鼻内催产素不调节跳跃到结论:精神分裂症中的S:与基线社会功能的潜在相互作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Oxytocin is a neuropeptide implicated in maintaining trust and affiliative behaviors in humans. Currently, there is great interest in exploring the therapeutic potential of oxytocin as an adjunct to conventional antipsychotic treatment for improving clinical and social cognitive symptoms in patients with schizophrenia. It has been well established that patients with schizophrenia show deficits in probabilistic reasoning tasks such that they quickly jump to conclusions without sufficient evidence. Since performance on this task is related to activation of prefrontal areas also implicated in social cognition, we explored whether intranasal oxytocin could improve probabilistic reasoning performance in stable medicated patients with schizophrenia. >Methods: Forty-three male, medicated patients with schizophrenia (Mean Age ± SD: 40.81 ± 11.44) and 16 matched healthy controls (Mean Age ± SD: 30.38 ± 9.85) participated in a double-blind, placebo-controlled, crossover study. Participants were required to complete the “Jumping to Conclusions” probabilistic reasoning task on 2 separate study visits (minimum 20 days apart). For each study visit, participants were randomized to receive either intranasal oxytocin (50 IU in solution) or intranasal placebo (saline). >Results: Consistent with previous findings, patients with schizophrenia showed deficits in probabilistic reasoning, jumping to conclusions more often than healthy controls, t(57) = 2.78, P = .007. Oxytocin did not significantly change probabilistic reasoning performance in patients, t(42) = −1.11, P = .27, nor in healthy controls, t(15) = −.62, P = .55). However, there was great variability in change in performance given oxytocin in patients. Exploratory analyses found that patients with lower bassline social functioning, as assessed by the Social Functioning Scale, showed more change on the probabilistic reasoning task given oxytocin, characterized by a reduced tendency to “jump to conclusions.” >Conclusion: Acute oxytocin does not appear to modify probabilistic reasoning in healthy controls and patients with schizophrenia. However, future studies should explore the potential confound of baseline social functioning.
机译:>背景:催产素是一种神经肽,与维持人类的信任和联谊行为有关。当前,对探索催产素作为常规抗精神病药物的辅助疗法以改善精神分裂症患者的临床和社会认知症状的兴趣很大。众所周知,精神分裂症患者在概率推理任务中表现出不足,因此他们在没有足够证据的情况下会迅速得出结论。由于这项任务的表现与社会认知相关的前额叶区域的激活有关,因此我们探讨了鼻内催产素是否可以改善精神分裂症稳定药物患者的概率推理能力。 >方法: 43名男性精神分裂症患者(平均年龄:40.81±11.44)和16名健康对照者(平均年龄:30.38±9.85)参加了双盲研究,安慰剂对照的交叉研究。要求参与者在2次单独的研究访问中(至少间隔20天)完成“跳转至结论”概率推理任务。对于每次研究访问,参与者被随机分配接受鼻内催产素(溶液中50 IU)或鼻内安慰剂(盐水)。 >结果:与先前的发现一致,精神分裂症患者显示出概率推理方面的缺陷,比健康对照组更容易得出结论,t(57)= 2.78,P = .007。催产素没有显着改变患者的概率推理表现,t(42)=-1.11,P = .27,在健康对照组中,t(15)=-。62,P = .55)。但是,在给患者服用催产素的情况下,性能变化存在很大差异。探索性分析发现,通过社交功能量表评估的低音社会功能较低的患者在给予催产素后,概率推理任务表现出更多变化,其特征在于“跳至结论”的趋势降低。 >结论:在健康对照和精神分裂症患者中,急性催产素似乎并未改变概率推理。但是,未来的研究应探讨基线社会功能的潜在混淆。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号